Creative Medical Technology Reports Early Success In CELZ-201-DDT Trial For Back Pain

… ongoing Phase 1/2 clinical trial of CELZ-201-DDT, a stem cell-based therapeutic for chronic back pain caused by degenerative disc disease or DDD.
Source: back pain